Last $58.15 USD
Change Today -0.06 / -0.10%
Volume 5.5M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brenton L. Saunders J.D.

Chief Executive Officer, President and Director, Actavis plc
AgeTotal Calculated CompensationThis person is connected to 41 board members in 3 different organizations across 9 different industries.

See Board Relationships
44--

Background*

Mr. Brenton L. Saunders, also known as Brent, J.D., has been the Chief Executive Officer and President of Actavis plc since July 1, 2014. Mr. Saunders served as Chief Executive Officer and President of Forest Laboratories Inc from October 1, 2013 to 2014. Mr. Saunders served as an Advisor of Valeant Pharmaceuticals International, Inc. since August 2013. He served as Senior Vice President of Compliance, Legal and Regulatory at HomeCare America. Mr. Saunders served as ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Director
2010-N/A
Former Chief Executive Officer and Director
2010-N/A
Former Chief Executive Officer and Director
2011-N/A
Former Chief Executive Officer, President, Director, Chairman of Compensation Committee and Member of Compliance Committee
2014-Present
Chief Executive Officer, President and Director

Education*

BA
University of Pittsburgh
JD
Temple University School Of Law
MBA
Fox School of Business and Management Temple University in Philadelphia

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $58.15 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.8M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
José E. Almeida Chairman, Chief Executive Officer and President
Covidien plc
$1.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.